Expression of functional formyl peptide receptors by human astrocytoma cell lines

被引:81
作者
Le, YY
Hu, JY
Gong, WH
Shen, WP
Li, BQ
Dunlop, NM
Halverson, DO
Blair, DG
Wang, JM [1 ]
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Div Basic Sci, Mol Immunoregulat Lab, Frederick, MD 21702 USA
[2] NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA
[3] NCI, Frederick Canc Res & Dev Ctr, Basic Res Lab, Frederick, MD 21702 USA
关键词
astrocytoma cells; chemotaxis; calcium mobilization; formyl peptide receptors; cytokines;
D O I
10.1016/S0165-5728(00)00373-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of astrocytes is important in the pathogenesis of a variety of diseases in the central nervous system, such as infection and neurodegeneration. We found that the bacterial chemotactic peptide, N-formyl-methionyl-leucyl-phenylalanine (fMLF) induced potent migration and Ca2+ mobilization in human astrocytoma cell lines. The effect of fMLF was pertussis toxin-sensitive, suggesting the involvement of seven transmembrane, G protein-coupled receptor(s) for fMLF. Scatchard analyses revealed that astrocytoma cell Lines express both high- and low-affinity binding sites for [H-3]fMLF. RT-PCR confirmed the expression of transcripts of fMLF receptors, the high-affinity FPR and the low-affinity FPRL1 by these cells. Both fMLF and F peptide, a synthetic peptide domain of HIV-1 envelope protein which specifically activates FPRL1, increased secretion of IL-6 by astrocytoma cells. Our study demonstrates for the first time that FPR and FPRL1 expressed by astrocytoma cell lines are functional, and suggests a molecular basis for the involvement of these receptors in host defense in the brain. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 33 条
[1]  
BANWAGONER NJ, 1999, J NEUROIMMUNOL, V100, P124
[2]   Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells [J].
Becker, EL ;
Forouhar, FA ;
Grunnet, ML ;
Boulay, F ;
Tardif, M ;
Bormann, BJ ;
Sodja, D ;
Ye, RD ;
Woska, JR ;
Murphy, PM .
CELL AND TISSUE RESEARCH, 1998, 292 (01) :129-135
[3]   EVOLUTION OF NEUROPATHOLOGIC ABNORMALITIES ASSOCIATED WITH BLOOD-BRAIN-BARRIER BREAKDOWN IN TRANSGENIC MICE EXPRESSING INTERLEUKIN-6 IN ASTROCYTES [J].
BRETT, FM ;
MIZISIN, AP ;
POWELL, HC ;
CAMPBELL, IL .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (06) :766-775
[4]   MITOCHONDRIAL N-FORMYLMETHIONYL PROTEINS AS CHEMOATTRACTANTS FOR NEUTROPHILS [J].
CARP, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :264-275
[5]   A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R [J].
Deng, XY ;
Ueda, H ;
Su, SB ;
Gong, WH ;
Dunlop, NM ;
Gao, JL ;
Murphy, PM ;
Wang, JM .
BLOOD, 1999, 94 (04) :1165-1173
[6]   The influence of cytokines on the integrity of the blood-brain barrier in vitro [J].
deVries, HE ;
BlomRoosemalen, MCM ;
vanOosten, M ;
deBoer, AG ;
vanBerkel, TJC ;
Breimer, DD ;
Kuiper, J .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (01) :37-43
[7]   MOLECULAR PROFILE OF REACTIVE ASTROCYTES - IMPLICATIONS FOR THEIR ROLE IN NEUROLOGIC DISEASE [J].
EDDLESTON, M ;
MUCKE, L .
NEUROSCIENCE, 1993, 54 (01) :15-36
[8]   TEMPORAL AND SPATIAL CHANGES OF QUINOLINIC ACID IMMUNOREACTIVITY IN THE IMMUNE-SYSTEM OF LIPOPOLYSACCHARIDE-STIMULATED MICE [J].
ESPEY, MG ;
MOFFETT, JR ;
NAMBOODIRI, MAA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (02) :199-206
[9]   IDENTIFICATION OF A HUMAN CDNA-ENCODING A FUNCTIONAL HIGH-AFFINITY LIPOXIN A(4) RECEPTOR [J].
FIORE, S ;
MADDOX, JF ;
PEREZ, HD ;
SERHAN, CN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (01) :253-260
[10]   Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor [J].
Gao, JL ;
Lee, EJ ;
Murphy, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (04) :657-662